Sbir phase II: analog front end (AFE) platform for lightweight, long-term, cortical monitoring

Ended Cooperative Agreement Awarded Last action

Award ID
2317290
Recipient
Awarding agency
Obligated
$1,345,748

Award facts

Completion date
Originally
Place of performance
Memphis, TN 38138, USA

Award details come from USAspending.gov.

Description

Abstract
The broader impact/commercial potential of this small business innovation research (sbir) phase II project provides next generation ambulatory seizure data acquisition. The advent of mobile health advances during the covid-19 health crisis have enabled new innovations to be considered. This effort provides a framework for the next line of remote neurological data acquisition capabilities for the implementation of military helmet designs that detect battlefield traumatic brain injuries, football helmet designs that detect sports-related brain injuries, caps for first responder teams that detect trauma, at-home monitoring headsets for remote migraine assessment, etc. A complete analogue front end (AFE) will be developed in order to provide digitized electroencephalograph (EEG) signals to the downstream stages. The project will have a major impact in several areas, namely, wearable BIO-devices, data fusion, and neurological data extraction and visualization of complex biological systems. This device can be utilized for first responders at the scene of neurological trauma such as emergency medical technicians, battle front medical areas, and sports related events. This small business innovation research phase II project will provide a robust mobile device that can be worn in an at-home setting for remote neurological monitoring. The solution will remove noisy artifacts from the electroencephalograph signal in order to perform neurological diagnoses and provide neurological reporting to the neurologist as an aid to quantify the patient?s seizure instances. The analogue front end (AFE) provides the foundation for a portable electroencephalograph (EEG) device for neurological data acquisition for the clinical, academic, and research communities. The ambulatory seizure monitoring device will enable an end-to-end system for robust, lightweight, data transmission to a cloud service, which will generate reports for the physician to analyze a patient neurological data for treatment. This system will extend the current rise of health devices into the complex environment of neurological states, as well as the eventual development of neuro-analytics. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.- subawards are not planned for this award.

Transactions

Action Obligated Date
Amendment $189,600
Amendment $192,689
Original award $963,459

Quick answers

Who received award 2317290?

2317290 was awarded to Neurodyne, .Inc. by National Science Foundation on September 1, 2023.

How much is award 2317290 worth?

$1,345,748 has been obligated on 2317290.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award